News

Metropolis Healthcare announced that the Board of Directors of the Company at its meeting held on 13 May 2026, inter alia, have recommended the Second Interim dividend of Rs 1 per equity Share (i.e. 50%) , subject to the approval of the shareholders.

Net profit of Metropolis Healthcare rose 74.67% to Rs 50.90 crore in the quarter ended March 2026 as against Rs 29.14 crore during the previous quarter ended March 2025. Sales rose 22.99% to Rs 424.68 crore in the quarter ended March 2026 as against Rs 345.29 crore during the previous quarter ended March 2025.For the full year,net profit rose 31.08% to Rs 190.02 crore in the year ended March 2026 as against Rs 144.97 crore during the previous year ended March 2025. Sales rose 23.64% to Rs 1645.85 crore in the year ended March 2026 as against Rs 1331.20 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales424.68345.29 23 1645.851331.20 24 OPM %25.4418.04 -24.3622.76 - PBDT108.2464.67 67 401.89299.53 34 PBT69.6536.04 93 268.17190.85 41 NP50.9029.14 75 190.02144.97 31 Powered by Capital Market - Live News

Metropolis Healthcare has allotted 4,200 equity shares under Metropolis-Restrictive Stock Unit Plan, 2020 on 13 May 2026. With this allotment, the paid up equity share capital has increased to 20,73,31,968 equity shares of Rs 2 each.

Metropolis Healthcare will hold a meeting of the Board of Directors of the Company on 13 May 2026.

Metropolis Healthcare has allotted 15,54,95,826 equity shares of face value of Rs 2/- each as fully paid equity shares, in the ratio of 3:1, to the eligible members of the Company whose names appeared in the Register of Members / Register of the Beneficial Owners, as on 20 March 2026, the `Record Date` fixed for this purpose. Consequent to the aforesaid allotment, paid-up share capital of the Company stands increased to Rs 41,46,55,536/- divided into 20,73,27,768 equity shares of face value of Rs 2/- each.Powered by Capital Market - Live News